Catalyst Pharmaceuticals
CPRX
#3932
Rank
$2.99 B
Marketcap
$24.37
Share price
0.74%
Change (1 day)
12.56%
Change (1 year)

Catalyst Pharmaceuticals (CPRX) Fails to deliver data

Key failure to deliver metrics for Catalyst Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Catalyst Pharmaceuticals (CPRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Catalyst Pharmaceuticals (CPRX) - since 2013

Volume in USD (price x number of shares), data since 2013

Catalyst Pharmaceuticals (CPRX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$0.91 M-75.2%
2024$3.7 M-58.64%
2023$8.95 M52.39%
2022$5.87 M25.46%
2021$4.68 M14.22%
2020$4.1 M-29.1%
2019$5.78 M708.56%
2018$0.71 M65.25%
2017$0.43 M-71.57%
2016$1.52 M37.6%
2015$1.1 M-77.4%
2014$4.89 M-25.66%
2013$6.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
BioMarin Pharmaceutical
BMRN
$2.28 M$10.82 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
$1.79 M$20.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$57.52 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/A$0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$29.26 M$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$34.98 M$0.43 B๐Ÿ‡บ๐Ÿ‡ธ USA